Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

ASTELLAS PHARMA US, INC

Filed by THEGROUP DC, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$70,000.00
Expenses
Not reported
Filing UUID
bb504083-8db8-435c-934b-cdc7dd6a2f6f
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.

Literal federal measure citations: H.R. 1300

PHA · Pharmacy

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.

Literal federal measure citations: H.R. 1300

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.